Cargando…
475. Does Metabolite Matter? Defining Target Itraconazole and Hydroxy-itraconazole Serum Levels for Blastomycosis
BACKGROUND: Itraconazole is first-line treatment for mild-moderate blastomycosis and consolidation of moderate-severe disease. Itraconazole is metabolized to 3 metabolites, including an active metabolite hydroxy-itraconazole. The sum of itraconazole and hydroxy-itraconazole levels > 1.0 mcg/mL is...
Autores principales: | Hess, Danielle, Abu Saleh, Omar M, Enzler, Mark, Jannetto, Paul J, Mara, Kristin, Stevens, Ryan W, Vergidis, Paschalis, Rivera, Christina G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752264/ http://dx.doi.org/10.1093/ofid/ofac492.533 |
Ejemplares similares
-
The Many Faces of Itraconazole Cardiac Toxicity
por: Teaford, Hilary R., et al.
Publicado: (2020) -
Laryngeal blastomycosis with subsequent heart failure from itraconazole therapy
por: Tsang, Daniel, et al.
Publicado: (2022) -
Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023) -
Ultra-performance liquid chromatography electrospray ionization–tandem mass spectrometry method for the simultaneous determination of itraconazole and hydroxy itraconazole in human plasma
por: Dwivedi, Ashish, et al.
Publicado: (2014) -
Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
por: Dhoot, Dhiraj, et al.
Publicado: (2023)